Tuon, Felipe F; Rymsza, Andrea M; Penteado Filho, Sergio R; Pilonetto, Marcelo; Arend, Lavinia N. V. S 
; Levin, Anna Sara Shafferman
Source: The journal of infection. Unidade: FM
Subjects: DOENÇAS INFECCIOSAS (CLASSIFICAÇÃO;DIAGNÓSTICO;MORTALIDADE;TERAPIA), INFECÇÃO HOSPITALAR (MORTALIDADE), CULTURA DE CÉLULAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, BACTEREMIA (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TUON, Felipe F et al. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta]. The journal of infection. Kent: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf. Acesso em: 19 fev. 2026. , 2011APA
Tuon, F. F., Rymsza, A. M., Penteado Filho, S. R., Pilonetto, M., Arend, L. N. V. S., & Levin, A. S. S. (2011). Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta]. The journal of infection. Kent: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdfNLM
Tuon FF, Rymsza AM, Penteado Filho SR, Pilonetto M, Arend LNVS, Levin ASS. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta] [Internet]. The journal of infection. 2011 ; 62( 3): 246-249.[citado 2026 fev. 19 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdfVancouver
Tuon FF, Rymsza AM, Penteado Filho SR, Pilonetto M, Arend LNVS, Levin ASS. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta] [Internet]. The journal of infection. 2011 ; 62( 3): 246-249.[citado 2026 fev. 19 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf
